| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |